ClinicalTrials.Veeva

Menu

Renal Function Post Cardioversion for Atrial Fibrillation (AFCARD-II)

H

Hadassah Medical Center

Status

Unknown

Conditions

Atrial Fibrillation
Cardioversion
Renal Insufficiency

Treatments

Other: Cardioversion
Other: Electrical atrial fibrillation Cardioversion

Study type

Observational

Funder types

Other

Identifiers

NCT02742207
HMO-15-0645

Details and patient eligibility

About

Atrial fibrillation is a common arrhythmia which requires electrical cardioversion in many patients in order to regain sinus rhythm. In a previous retrospective study a complication of acute renal failure was found in 17% of the patients after cardioversion.(The incidence and prognosis of renal dysfunction following cardioversion of atrial fibrillation. Helman Y,...Gilon D et al:Cardiology 2013;124(3);184-9.) Another complication previously described after cardioversion is pulmonary edema.

In this prospective study the investigators aim to evaluate the risk of acute renal failure post cardioversion. In addition the investigators would like to evaluate hemodynamic changes, fluid balance and sodium levels in patients post cardioversion as a potential mechanism for both acute renal failure and pulmonary edema post cardioversion. In order to assess hemodynamic changes the investigators will use a non-invasive FDA approved device called NICaS (Non-Invasive Cardiac System). This system calculates cardiac output, cardiac index and peripheral vascular resistance in a non-invasive, fast and accurate way.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with new onset atrial fibrillation

Exclusion criteria

  • Pregnant

Trial design

150 participants in 1 patient group

Observational
Description:
All comers with Atrial fibrillation
Treatment:
Other: Electrical atrial fibrillation Cardioversion
Other: Cardioversion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems